Global 3D Printing Materials Market: Environmentally Sustainable Plastics to Gain Preference over Oil-based Plastics as 3D Printing Materials

With growing demand for 3D printing technology, the market for 3D printing materials is on the rise. With the help of materials such as plastics, ceramics, metals, laywood, and wax, digital designs are converted into tangible objects in 3D printing. The global market for 3D printing is projected to expand at a CAGR of 18.0% during the period between 2014 and 2020. The overall market was worth US$0.4 bn in 2013 and is estimated to reach a valuation of US$1.4 bn by 2020. In terms of volume, the global 3D printing materials market stood at 2 bn kg.

Browse Full Report: http://www.transparencymarketresearch.com/3d-printing-materials-market.html

Plant-Based Plastics: A Popular Choice as 3D Printing Material

Manufacturers of 3D printers are focussing on the development of new 3D printing materials that would provide high-strength 3D models with improved surface finish. Among the extensively used 3D printing materials, plastics account for the largest share in the global 3D printing materials market and held a 48% market share in terms of volume in 2013. Increasing demand for electronics and consumer products is expected to further fuel the demand for plastics as 3D printing materials.

Lately, plant-based plastics have emerged as a popular choice for 3D printing, as they are easier to work with during processing and are environmentally sustainable. Oil-based printing filaments are still widely used owing to the higher softening point exhibited by them, which leads to more flexible 3D models that will bend before breaking. However, plant-based plastics are gaining preference over oil-based printing filaments. Biome Bioplastics, in partnership with 3Dom Filaments, has developed Biome3D, a biodegradable thermoplastic made from plant starches that combines superior print finish and easy processing while offering higher print speeds. High-performance plant-based plastics as 3D printing materials would offer potential environmental benefits along with improved efficiency and customizability.

Future Developments in Biomaterials for 3D Printing

For sustainable 3D printing, researchers are working on integrating various desired properties into existing bioplastics. ‘Smart’ biobased plastics display one or more properties that can be altered by external stimuli such as temperature, pressure, light, and magnetic and electric fields. For example, some of the 3D printing polymers change shape or colour with an increase or decrease in temperature, while some are self-healing. These smart features in 3D printing materials will give rise to a whole range of new products and applications.

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/3d-printing-materials-market.htm

Some of the future biomaterials for 3D printing are thermo chrome PLA, Nylon 11, Flex PLA or Soft PLA, Bio Rubber, straw and bamboo-based biomaterials, and laybrick. Thermo chrome PLA filament changes colour in response to temperature alterations. While Flex PLA or Soft PLA and Nylon 11 are remarkably flexible, straw-based and bamboo-based 3D printing filaments are of low cost. These diverse sets of properties will help the 3D printing materials market gain customers in a wide-ranging set of applications.

Global Foot and Mouth Disease (FMD) Vaccines Market to Grow at CAGR of 8.8% by 2020

The global foot and mouth disease (FMD) vaccines market was valued at US$0.51 billion in 2013 and is predicted to be valued at US$0.95 billion by 2020. Rising cases of FMD in countries such as India, Malaysia, China, Africa, South Korea, and Algeria will allow the global foot and mouth disease vaccines market to grow at a CAGR of 8.8% from 2014 to 2020. 

Browse Full Market Research Report on Foot and Mouth Disease Vaccines Market: http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html

Asia Pacific Driving Global Foot and Mouth Disease Vaccines Market

The growing number of people suffering from foot and mouth disease has resulted in the steady growth of the global foot and mouth disease vaccines market. The global FMD vaccines market is geographically segmented into Europe, Asia Pacific, North America, and other countries from around the globe. Asia Pacific drives the global foot and mouth disease vaccines market geographically. Holding a 70% share in the global market, the APAC market is led by countries such as China, India, Pakistan, Bangladesh, Hong Kong, and South Korea. Nonetheless, Europe and North America are expected to have some influence on the foot and mouth disease vaccines market in the forecast period. 

Lately, a high number of FMD cases was recorded in countries from Rest of the World. Viral FMD, commonly seen in children, was recorded in some regions, equally prevalent among babies and adults.

FMD in babies is frequently seen in daycares due to frequent diaper changes. Most of the children affected by foot and mouth disease were from daycares, where viral illnesses can easily spread. According to Dr. Jay Marque, associated with Lake Charles Urgent Care, if any rashes, burns, blisters, or sores are seen on feet, face, or hands, it is a clear sign of foot and mouth disease. As foot and mouth disease is viral, antibiotics don’t provide quick relief. Thus the growing importance of FMD vaccines. Increasing frequency of FMD around the globe has resulted in the growth of the global foot and mouth disease vaccines market. 

High prevalence of foot and mouth disease, especially in Asian countries, Latin America, and the Middle East, has led to growth of the global foot and mouth disease FMD vaccines market. Agrovet Co., Brilliant Bio Pharma Ltd., Intervac Pvt. Ltd., Biogenesis Bago, and Merial are some of the leading players in the global foot and mouth disease FMD vaccines market. 

Browse Press Release on Foot and Mouth Disease Vaccines Market: http://www.transparencymarketresearch.com/pressrelease/foot-mouth-disease-vaccines.htm

Global Foot and Mouth Disease Vaccines Market Driven by Oil-based Vaccines

In 2013, the global FMD vaccines market was driven by oil-based vaccines. 63% of the total market was accounted for by oil-based vaccines. The global foot and mouth disease vaccines market is also segmented on the basis of geography and application. On the basis of application, the global foot and mouth disease FMD vaccines market is divided into pigs, cattle, goats, sheep, and others. Rise in the frequency of foot and mouth disease in livestock has directly affected the meat and dairy industries. As a result, the meat and dairy industries will contribute heavily towards the growth of the global foot and mouth disease vaccines market. 

Need for Precise Diagnostics for Brain Injuries to Boost Demand for Contrast Media Injectors

The use of intravenous contrast media in computerized tomography (CT) is of paramount importance to improve diagnostic accuracy. In radiological diagnostics, many times, the difference between certain organs or tissues may not be evident. For such cases, the utilization of contrast agents highlights body cavities to be distinguished from each other.

Browse Full Market Research Report on Contrast Media Injectors Market: http://www.transparencymarketresearch.com/contrast-media-injectors.html

With the manifestation of ever-increasing technological sophistication in healthcare from manifold manual injectors to stop-cocks to automated types, contrast injectors have evolved phenomenally for higher precision. These automated contrast media injectors are known as autoinjectors and offer a range of benefits, such as lower quantity of contrast media required to be injected, and also can monitor the patient if the dosage needs to be increased to keep pace with advanced medical imaging scanners. 

Trends in Contrast Media Injection Systems Market

Over the past few years, the use of dual-head injectors over single-head ones, integration of electronic medical record (EMR) systems, and features for improved patient safety have come to the fore among the trends impacting the automated contrast media injection systems market. 

In the past decade, as a standard industry switch, single-head injectors developed in the 1970s have been replaced by dual-head injectors. The use of dual-syringe injectors has the advantage of reduced use of the contrast medium – alternate flow of saline and contrast media from the first and second head, respectively, into the veins helps reduce cost considerably. 

Additionally, according to the experience of users, contrast media delivery, if administered through a dual-head injector, is much more efficient and controlled. These devices are also equipped to synchronize with the extremely quick imaging times offered by new multi-detector scanners for computed tomography.

Contrast Media Injectors (CMI) Market – A Snapshot

Worldwide, with increasing incidence of several life-threatening conditions, there has been a persistent rise in demand for imaging diagnostics such as CT and MRI. This in turn is driving demand for efficient contrast media injectors. 

Furthermore, increasing awareness about early diagnosis of disorders has also led to increased usage of imaging procedures, thus fueling the contrast media injectors market.

For such reasons, research carried out by Transparency Market Research (TMR) projects the global contrast media injectors market to be valued at US$886.7 million by 2020, increasing from US$630.1 million in 2013 at a 5.0% CAGR from 2014 to 2020.

Presently, widespread deployment of CT machines due to their multitude of advantages, such as low cost and greater patient compliance, over positron emission tomography (PET) and MRI is boosting demand for CT injectors. Thus, CT injectors are the fastest growing injector type in the overall contrast media injectors market.

CMI-induced imaging enables bolus chasing and control of media flow, thus resulting in significant improvement in radiographic images. Contrast-enhanced imaging is mostly used for neurological. gastrointestinal, oncological, and musculoskeletal diseases. 

Browse Press Release on Contrast Media Injectors Market: http://www.transparencymarketresearch.com/pressrelease/contrast-media-injectors-market.htm

In the present scenario, MRI and CT imaging procedures find extensive application in neurological conditions. Neuroimaging (CT, PET, MRI, and others) carried out with contrast media are optimally suited to detecting brain injuries, tumor, intracranial hemorrhages, and acute neurological changes. 

According to a study published in NeuroRX on brain injury, approximately 1.6 million head injuries are reported in the U.S every year, with 48% (moderate to severe) of these injuries requiring medical imaging. Hence, North America accounts for a major chunk of revenue in the contrast media injectors market.

UNICEF-led Initiatives for Use of Contraceptives for Improved Maternal Health in Third World Countries to Push Market to New Heights

According to the World Health Organization, globally, in 2013, 289,000 deaths of women were reported during pregnancy and childbirth, a 45% decline from the 1990 mortality level. Most deaths occurred due to unavailability of skilled regular and emergency care. Since 1990, maternal mortality has more than halved in countries in Northern Africa and Asia.

Browse Full Market Research Research Report on Contraceptives Market: http://www.transparencymarketresearch.com/contraceptives-market.html

Despite improved access to maternal healthcare, in sub-Saharan Africa, the risk of maternal death remains very high, at 1 in 38. 

Worldwide, more than 10% women either do not have access to or do not use effective contraception methods. The global number of maternal deaths can be cut by as much as one-third if the family planning needs are satisfied by universal access to contraception. 

Contraceptives – Best Way to Prevent Sexually Transmitted Diseases

“Safe sex”, today, means protection from unintended pregnancy as well as sexually transmitted diseases (STD). These complications, which arise out of sexual activity, have serious biological and clinical implications, thus the selection of contraception is of paramount importance.

Whilst STDs pose a health risk to everyone, women are positioned to lose more than men due to irresponsible sexual behavior. So much so that STDs can cause serious damage and may even lead to permanent infertility or death. 

Sexual activity among teenagers with multiple sex partners is strongly linked with cervical cancer in the long run – a disease that men don’t need to bother about. Women who are carriers of STDs have more chances of passing the disease to their baby, causing infant sickness or even death.

How do Contraceptives Prevent Unintended Pregnancy?

For Men

Condoms – they are usually made from latex rubber and act as a barrier to prevent contact between the vagina and semen, genital lesions, and infectious genital discharges. 

Male Sterilization – this is a quick procedure that blocks or cuts the tubes that carry the sperm from the testicle to the penis.

For Women

Diaphragm – this is a rubber disk with a stretchable rim and is used to cover the cervix.

Oral Contraceptives – these give protection against pregnancy by a combination of progestin and estrogen.

Depo-Provera – this is a hormone-based contraceptive that is meant to be injected.

Implants – these are synthesized from small rubber rods and are surgically implanted under the skin to release contraceptive steroids.

IUD – this is a T-shaped device, which is a placed inside the uterus by a healthcare professional.

Female Sterilization – permanent contraception done surgically.

Emergency Contraception – this is a chemical contraceptive that needs to be taken within 72 hours of unprotected sex to prevent unplanned pregnancy.

Browse Press Release on Contraceptives Market: http://www.transparencymarketresearch.com/pressrelease/contraceptives-market.htm

Morning After IUD – needs to be taken within 5 days of unprotected sex.

Industry Activities Raise Awareness about Contraceptives

Bayer Healthcare, a major market player for contraceptives, along with several NGOs, observes September 26th as World Contraception Day every year. This helps raise awareness about the advantage of contraceptives. In North America, implementation of the Affordable Care Act for favorable reimbursement policies for contraceptives has boosted the contraceptives market.

Global CINV Drugs Market: Review of the Existing Drugs and Pipeline Drugs

Chemotherapy-induced nausea and vomiting is the most dreaded effect of chemotherapy. These side effects associated with chemotherapy can greatly affect the quality of life of the patient. According to medical sources, around 70% to 80% of cancer patients going through chemotherapy experience nausea and vomiting as major side effects. Players in the global chemotherapy-induced nausea and vomiting (CINV) drugs market are involved in intensive research and development activities to offer cancer patients drugs that help manage CINV better.

Browse Full Market Research Report on CINV Existing and Pipeline Drugs Market: http://www.transparencymarketresearch.com/cinv-market.html

Existing Drugs for CINV and Impact of Patent Expiry

Some of the major drugs in the global chemotherapy-induced nausea and vomiting (CINV) drugs market are Aloxi (palonosetron), Akynzeo (netupitant-palonosetron FDC), Emend (aprepitant), Kytril Generic (granisetron), and Zofran Generic (ondansetron).

Patents for key drugs such as Aloxi and Emend are going to expire in 2015. As a result, many manufacturers are expected to enter the industry with generic versions of these two brands and these cheaper versions will be sold for a price 80% lower than the branded drugs. This is expected to suppress the growth of the overall chemotherapy induced nausea and vomiting (CINV) drugs market.

According to a market research firm, Transparency Market Research (TMR), the global chemotherapy-induced nausea and vomiting (CINV) drugs market will expand at a moderate CAGR of 5.7% during the forecast period of 2014 to 2020. In 2013, the global CINV drugs market was worth US$1.28 billion and by 2020, the market is expected to be worth US$1.88 billion.

Major Pipeline Drugs for CINV and Other Emerging Drugs

There are several drugs in the global chemotherapy induced nausea and vomiting (CINV) drugs market to manage the condition. However, these side effects continue to be a major concern for oncologists and patients. Several companies in the global chemotherapy induced nausea and vomiting drugs market are striving to develop novel and more effective therapeutic solutions to manage CINV. Some of these companies are Heron Therapeutics, Helsinn Holding, and Tesaro.

Two key drugs to treat CINV that are currently in the pipeline are Rolapitant and SUSTOL (granisetron injection extended release). Rolapitant is a new oral drug that has a long plasma half-life. Currently, it is undergoing review by the FDA. In many studies, rolapitant regimen demonstrated statistically superior complete response rates as compared to granisetron control during the delayed phase. Other emerging new agents from the most recent trials include netupitant/palonosetron (NEPA).

Browse Press Release on CINV Existing and Pipeline Drugs Market: http://www.transparencymarketresearch.com/pressrelease/cinv-market.htm

In addition to this, there are studies that are evaluating the benefits of other substances such as ginger and olanzapine to prevent CINV. According to an Oxford Journal (Annals of Oncology), presently, studies exploring the optimal use of antiemetics in situations where high-dose chemotherapy is administered have been lacking. However, the evidence in favor of NK1RA (neurokinin-1 receptor antagonist) is accumulating.

More research is required to better understand nausea related to CINV in order to optimize the combinations and dosage of the existing or emerging drugs in chemotherapy situations.

Recombinant Albumin to Open New Growth Avenues for the Global Albumin Market

Albumin is also called the main defense regulation protein of our body. A well-described carrier protein, albumin has high concentration of plasma (nearly 55% of body’s total plasma content) and is known for its many uses in the field of pharmaceuticals and medical devices.

The major functions of albumin market include the transportation of fatty acids to tissues, stabilization of protein, and inducing an antioxidant effect in plasma. The high concentration of plasma and interstitial space makes albumin effective in controlling body fluids, leading to its use as a plasma volume expander for many decades. Along with the therapeutic and diagnostic properties of albumin, it is also a very well known excipient.

Browse Full Market Research Report on Albumin Market: http://www.transparencymarketresearch.com/albumin-market.html

Albumin’s use an excipient, a substance that acts as a binding material to combine with active ingredients and facilitate the transport of drug in the body, has widespread applications in the fields of drug manufacture, drug delivery, medical device coatings, and vaccine manufacture. It is also used widely as a component of media in the production of vaccines.

Traditionally, albumin has been sourced from either bovine or human serum. Obtaining albumin from these sources also results in a number of concerns regarding reliability of supply, blood borne contaminations through mycoplasma, prions, and viruses, and variability in the performance of the product. As a result, there is an increased demand for replacement of albumin obtained from an animal-free source, especially in the biopharmaceutical industry. To benefit from this lucrative growth opportunity, many companies are developing high quality, animal-free strains of recombinant albumin from some plant seeds.

There are many benefits of recombinant albumin over animal-derived albumin, including: 

• Excellent functionality suited for a huge set of applications
• Consistent, high-quality, and consistent core ingredient
• Capability of being produced in a large-scale, animal-free way complaint with regulatory standards
• Structurally and biochemically similar to animal-derived albumin, but without any side effects associated with human and animal derived albumin
• Better consistency, regulatory compliance, and safety

Paradigm Shift from Human Serum Albumin to Animal-free Recombinant Albumin

According to a report published by Transparency Market Research, the global market for albumin had a valuation of US$707.9 million in 2013. By developing at a low, albeit positive, 2.3% CAGR between 2014 and 2020, the market will rise to US$828.2 million by 2020. 

While factors such as technological advances in the field of protein purification and improved product stability are creating positive growth prospects for the market, the rising demand for animal-free recombinant albumin is reshaping the market’s structure. The increasing demand for animal-free recombinant albumin has also presented before the market numerous growth opportunities in terms of untapped application areas.

Browse Press Release on Albumin Market: http://www.transparencymarketresearch.com/pressrelease/albumin-market.htm

Till 2013, the market segment for human serum albumin remained the leading revenue generator of the global albumin market. However, the rising demand for this market segment could get inhibited in the coming years owing to mounting concern regarding certain impurities in human serum albumin, a factor that has prompted researchers to look for alternatives. Rising concerns regarding cruelty towards bovine fetuses in the process of deriving bovine serum has also prompted researchers and manufacturers to look for effective alternatives. As a result, the market segment of animal-free recombinant albumin is expected to rise grow at the fastest pace amongst the other two albumin types, human serum albumin and bovine albumin.

Catheter-associated Urinary Tract Infections to Restrain Growth of Global Urinary Catheters Market

Urinary catheters are commonly recommended to patients suffering from urinary incontinence, urinary retention, and other medical conditions such as dementia, multiple sclerosis, and spinal cord injury. Surgery on the prostate or genitals also requires the usage of urinary catheters. The increasing demand for urinary catheters among geriatric population, coupled with increasing prevalence of disorders such as urinary retention and urinary incontinence, is expected to push the global urinary catheters market at a CAGR of 5.1% during the period from 2014 to 2020. The global urinary catheters market stood at US$1.66 billion in 2013 and is estimated to reach a valuation of US$2.37 billion by 2020. 

Browse Full Market Research Report on Urinary Catheters Market: http://www.transparencymarketresearch.com/urinary-catheters-market.html

Prolonged use of urinary catheters leads to urinary tract infections. Catheter-associated urinary tract infections or CAUTIs are one of the most common hospital-acquired infections. A significant percentage of hospitalized patients are recommended to use urinary catheters during their hospital stay. Prolonged use of the urinary catheters can cause infection in any part of the urinary system, including bladder, urethra, ureters, and kidney. CAUTIs have been associated with rise in healthcare costs, extended hospital stay, and mortality. It has been observed largely that CAUTIs are caused due to the presence of an indwelling urinary catheter. Though the prevalence of CAUTI is widespread among hospitalized patients, it can be reasonably prevented. Most CAUTIs can be treated with antibiotics and removal or change of the catheter. 

Hospitals Need to Implement Effective Strategies to Reduce Prevalence of CAUTIs

The guidelines released by the Centers for Disease Control and Prevention for prevention of CAUTIs emphasize on the proper use, insertion, and maintenance of urinary catheters in different healthcare settings. The risk of CAUTIs can be significantly reduced by ensuring the usage of catheters only when needed and removal as early as possible, by placing catheters through proper aseptic technique, and maintaining closed sterile drainage system. 

It is a widely accepted fact that most hospitals have not implemented effective strategies for preventing CAUTIs. According to the American Nurses Association, there are three areas to improve clinical care to reduce the incidence of CAUTIs:

• Timely removal of urinary catheters.
• Prevention of inappropriate short-term catheter use.
• Urinary catheter care during placement.

Before placing any indwelling urinary catheter, it is important to properly assess patient for accepted conditions and alternatives. Documenting all instances of indwelling urinary catheters such as insertion date, indication, and removal date can significantly prevent the prevalence of CAUTIs.

Browse Press Release on  Urinary Catheters Market: http://www.transparencymarketresearch.com/pressrelease/urinary-catheters-market.htm

Condom (External) Catheters- A Potential Alternative to Indwelling Foley Catheters

In order to prevent CAUTIs, antimicrobial catheters, suprapubic catheters, condom catheters, penis pouches, and intermittent catheterization are some of the potential alternatives to indwelling urinary catheters. Condom (external) catheters are generally used to substitute indwelling Foley catheters in the hospitals. Antimicrobial urinary catheters such as silver-alloy and nitrofurazone impregnated catheters are expected to prevent the risk of CAUTIs during short term catheterization. However, there are not sufficient studies to support the effectiveness of antimicrobial catheters during long-term use (more than 30 days). 

Recombinant Albumin to Open New Growth Avenues for the Global Albumin Market

Albumin is also called the main defense regulation protein of our body. A well-described carrier protein, albumin has high concentration of plasma (nearly 55% of body’s total plasma content) and is known for its many uses in the field of pharmaceuticals and medical devices.

The major functions of albumin market include the transportation of fatty acids to tissues, stabilization of protein, and inducing an antioxidant effect in plasma. The high concentration of plasma and interstitial space makes albumin effective in controlling body fluids, leading to its use as a plasma volume expander for many decades. Along with the therapeutic and diagnostic properties of albumin, it is also a very well-known excipient.

Browse Full Market Research Report on Albumin Market: http://www.transparencymarketresearch.com/albumin-market.html

Albumin’s use an excipient, a substance that acts as a binding material to combine with active ingredients and facilitate the transport of drug in the body, has widespread applications in the fields of drug manufacture, drug delivery, medical device coatings, and vaccine manufacture. It is also used widely as a component of media in the production of vaccines.

Traditionally, albumin has been sourced from either bovine or human serum. Obtaining albumin from these sources also results in a number of concerns regarding reliability of supply, blood borne contaminations through mycoplasma, prions, and viruses, and variability in the performance of the product. As a result, there is an increased demand for replacement of albumin obtained from an animal-free source, especially in the biopharmaceutical industry. To benefit from this lucrative growth opportunity, many companies are developing high quality, animal-free strains of recombinant albumin from some plant seeds.

There are many benefits of recombinant albumin over animal-derived albumin, including: 

• Excellent functionality suited for a huge set of applications
• Consistent, high-quality, and consistent core ingredient
• Capability of being produced in a large-scale, animal-free way complaint with regulatory standards
• Structurally and biochemically similar to animal-derived albumin, but without any side effects associated with human and animal derived albumin
• Better consistency, regulatory compliance, and safety

Paradigm Shift from Human Serum Albumin to Animal-free Recombinant Albumin

According to a report published by Transparency Market Research, the global market for albumin had a valuation of US$707.9 million in 2013. By developing at a low, albeit positive, 2.3% CAGR between 2014 and 2020, the market will rise to US$828.2 million by 2020. 

While factors such as technological advances in the field of protein purification and improved product stability are creating positive growth prospects for the market, the rising demand for animal-free recombinant albumin is reshaping the market’s structure. The increasing demand for animal-free recombinant albumin has also presented before the market numerous growth opportunities in terms of untapped application areas.

Browse Press Release On Albumin Market: http://www.transparencymarketresearch.com/pressrelease/albumin-market.htm

Till 2013, the market segment for human serum albumin remained the leading revenue generator of the global albumin market. However, the rising demand for this market segment could get inhibited in the coming years owing to mounting concern regarding certain impurities in human serum albumin, a factor that has prompted researchers to look for alternatives. Rising concerns regarding cruelty towards bovine fetuses in the process of deriving bovine serum has also prompted researchers and manufacturers to look for effective alternatives. As a result, the market segment of animal-free recombinant albumin is expected to rise grow at the fastest pace amongst the other two albumin types, human serum albumin and bovine albumin.

Catheter-associated Urinary Tract Infections to Restrain Growth of Global Urinary Catheters Market

Urinary catheters are commonly recommended to patients suffering from urinary incontinence, urinary retention, and other medical conditions such as dementia, multiple sclerosis, and spinal cord injury. Surgery on the prostate or genitals also requires the usage of urinary catheters. The increasing demand for urinary catheters among geriatric population, coupled with increasing prevalence of disorders such as urinary retention and urinary incontinence, is expected to push the global urinary catheters market at a CAGR of 5.1% during the period from 2014 to 2020. The global urinary catheters market stood at US$1.66 billion in 2013 and is estimated to reach a valuation of US$2.37 billion by 2020. 

Browse Full Market Research Report on Urinary Catheters Market: http://www.transparencymarketresearch.com/urinary-catheters-market.html

Prolonged use of urinary catheters leads to urinary tract infections. Catheter-associated urinary tract infections or CAUTIs are one of the most common hospital-acquired infections. A significant percentage of hospitalized patients are recommended to use urinary catheters during their hospital stay. Prolonged use of the urinary catheters can cause infection in any part of the urinary system, including bladder, urethra, ureters, and kidney. CAUTIs have been associated with rise in healthcare costs, extended hospital stay, and mortality. It has been observed largely that CAUTIs are caused due to the presence of an indwelling urinary catheter. Though the prevalence of CAUTI is widespread among hospitalized patients, it can be reasonably prevented. Most CAUTIs can be treated with antibiotics and removal or change of the catheter. 

Hospitals Need to Implement Effective Strategies to Reduce Prevalence of CAUTIs

The guidelines released by the Centers for Disease Control and Prevention for prevention of CAUTIs emphasize on the proper use, insertion, and maintenance of urinary catheters in different healthcare settings. The risk of CAUTIs can be significantly reduced by ensuring the usage of catheters only when needed and removal as early as possible, by placing catheters through proper aseptic technique, and maintaining closed sterile drainage system. 

It is a widely accepted fact that most hospitals have not implemented effective strategies for preventing CAUTIs. According to the American Nurses Association, there are three areas to improve clinical care to reduce the incidence of CAUTIs:

• Timely removal of urinary catheters.
• Prevention of inappropriate short-term catheter use.
• Urinary catheter care during placement.

Before placing any indwelling urinary catheter, it is important to properly assess patient for accepted conditions and alternatives. Documenting all instances of indwelling urinary catheters such as insertion date, indication, and removal date can significantly prevent the prevalence of CAUTIs. 

Get Sample Report on Urinary Catheters Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3936

Condom (External) Catheters- A Potential Alternative to Indwelling Foley Catheters

In order to prevent CAUTIs, antimicrobial catheters, suprapubic catheters, condom catheters, penis pouches, and intermittent catheterization are some of the potential alternatives to indwelling urinary catheters. Condom (external) catheters are generally used to substitute indwelling Foley catheters in the hospitals. Antimicrobial urinary catheters such as silver-alloy and nitrofurazone impregnated catheters are expected to prevent the risk of CAUTIs during short term catheterization. However, there are not sufficient studies to support the effectiveness of antimicrobial catheters during long-term use (more than 30 days). 

How Thermal Energy Storage Can Benefit the Rising Power Consumption in the World

The global thermal energy storage market is growing at a CAGR of 16.7% from 2014 to 2020. The market was worth US$627.6 million in 2013 and this CAGR will propel it to US$1,818.8 million by 2020. In terms of capacity, the global thermal energy storage market is growing at a CAGR of 17.1% from 2014 to 2020. The capacity of 2,083.3MW in 2013 is expected to eventually reach 6,070.2MW in 2020.

Browse Full Market Research Report on Thermal Energy Storage Market: http://www.transparencymarketresearch.com/thermal-energy-storage-market.html

The primary growth driver of the global thermal energy storage market is the demand for cost-effective, efficiently produced, and reliable electricity. The market’s largest segment at present is the sensible heat technology thermal energy storage. The share of this segment, however, is set to reduce over time, mainly due to the rather low per unit storage capacity it offers. Sensible heat technology is slowly but surely being overtaken by thermochemical heat storage and latent heat storage technologies. Most experts believe the two segments have what it takes to remove sensible heat from its pole position.

Within all the end users of thermal energy storage, a majority share was held by the commercial and industrial segment in 2013. The segment is expected to continue its dominance till 2020 at the very least. The segment has been in the lead ever since the growth restraint of unavailability of products was brought under control in 2010.

Could Upfront Investments Hamper the Global Thermal Energy Storage Market?

The bottom line is that the requirement of a grid interconnection and a heavy requirement for upfront investment are the two factors that threaten to check the market. However, many countries that previously neglected the global thermal energy storage market are now beginning to understand the importance of the technology and are showing increased interest in terms of investments. Among the regional markets, Europe dominated – and will continue to dominate – the global thermal energy storage scene. Between 2013 and 2020, Europe is likely to add almost 1,3070MW capacity of thermal energy storage.

The top players in the global thermal energy storage market are TAS Energy, Steffes Corporation, Ice Lings, FAFCO Thermal Storage Systems, Caldwell Energy, Burns & McDonnell, BrightSource Energy, Inc., Baltimore Aircoil Company, and Abengoa Solar SA. Each company has a valuable innovation drive that will propel the global thermal energy storage market.

Ice Energy Breakthroughs to Pave the Way

Ice Energy has been making waves in the global thermal energy storage market recently. The distributor has paired up with NRG Energy Inc. to contain the energy demand situation in California. They have come up with a solution that will use energy storage peak load management solutions to reduce peak power consumption. They will be using 1,800 Ice Bear ice storage units to achieve this. The company is also planning to extend its award-winning Ice Bear energy solution towards reducing small residential peak energy consumption. They have bagged a five-year contract to provide 5MW thermal energy for behind-the-meter consumption. In other places, Promethean Power Systems is attempting to use thermal energy storage to help ease the power consumption in parts of rural India where milk is produced and processed.

Browse Press Release On Thermal Energy Storage Market: http://www.transparencymarketresearch.com/pressrelease/thermal-energy-storage-market.htm

With breakthroughs like these, the global thermal energy storage market is set to create a necessary safety net for the world’s power crisis. It is one of the safest and cleanest energy storage methods available today. Many countries are taking notice of this and are looking for ways to introduce the same into their power grids.

Industrialization Opens up New Avenues for Global Lubricants Market

The global lubricants market is estimated to grow at a CAGR of 1.72% from 2014 to 2020. The market’s volume in 2013 was 39,140.12 kilo tons. By the end of 2020, the global lubricants market should total reach a volume of 44,165.11 kilo tons. The greatest reason for this growth is the rapid rate of industrialization in most emerging economies of the world. But things are not as simple as they seem for the global lubricants market. A faster rate of development also implies the substitution or elimination of conventional lubricants. Major players in the market are therefore attempting strategies to sustain themselves against the restrictions and use the new technology wave to come up with new, eco-friendly products.

Browse Full Market Research Report on Lubricants Market: http://www.transparencymarketresearch.com/lubricants-market.html

The global lubricants market has so far been dominated by the mineral oil segment in terms of products. The segment singled itself out in the market with a whopping 80% share in 2013. The segment is, however, witnessing quite a bit of opposition due to the environmental impact it has had. In direct contrast to this situation is the biobased lubricants segment, which is expected to be the fastest growing one in the global lubricants market.

Love-hate Between the Markets for Lubricants and Automobiles

It is logical to think that the global automotive market is one of the largest consumers of lubricants. By volume, the automotive market, as a lubricants consumer, took up 50% of the market. Lubricants are needed by vehicles for as long as they are in use. Now that the automobile market is booming, we can see its direct relation to demand from the global lubricants market. But this demand does not come without caveats. At the top of the long list of lubricant requirements for today’s vehicles is for them to be environmentally safe. Manufacturers are struggling to essentially let go of the conventional methods that, although efficient, have caused much harm to the ecosystem.

At the same time, we have the fast-growing segments of electric and hybrid vehicles. Vehicles are already showing a much larger timeframe between oil changes. Adding hybrids to that mix reduces the demand for lubricants even further. The global lubricants market is no longer needed by the entire automobile industry, leaving all but the top players to need to innovate to stay in existence.

Are Oil Prices Affecting the Global Lubricants Market?

A recent move by Royal Dutch Shell PLC shows that the falling oil prices could be working against the global lubricants market. In an attempt to shed assets and recover losses, Shell has sold off its Chinese lubricants business’ majority stake to Carlyle Group LP. This has given the private-equity firm a very rare chance to enter the China energy industry. Shell, on the other hand, said they are going to focus on selling their own lubricants brands inside China.

Browse Press Release On Lubricants Market: http://www.transparencymarketresearch.com/pressrelease/lubricants-market.htm

Two nations that are showing a remarkable rate of growth are India and China. Both nations are showing improvements in GDP. The expansion of all industries in these two nations, especially automotive, are set to light up the future of the global lubricants market.

Upbeat Medical Applications Segment of Styrenic Polymers: How it became an Alternative to PVC as the Polymer for Healthcare

The global styrenic polymers market is growing at a CAGR of 7.5% from 2014 to 2020. The market was worth US$2.08 billion in 2013 and will reach a value of US$3.29 billion by 2020. Additionally, the global styrenic polymers market’s net volume in 2013 was 806.7 kilo tons and will continue to grow strongly till 2020.

Styrenic polymers are a family of plastic products that use styrene as their core building block. They are useful due to their various favorable properties, such as thermoplasticity, thermal insulation, low weight, strength, durability, and the ability to choose the level of opacity or color of a product using styrenic polymers. All the above qualities are in heavy demand in the medical industry.

Browse full Market Research Report on Styrenic Polymers Market: http://www.transparencymarketresearch.com/styrenic-polymers-market.html

PVC vs. Styrenic Polymers

The global styrenic polymers market can be segmented into multiple segments, including polystyrene, styrene acrylonitrile, and acrylonitrile butadiene styrene. In terms of medical applications, polystyrene is the only commodity that is used and thus garners a majority share. SEBS and SBS, other synthetic block copolymers, are also in high demand in medical applications. They are used for the manufacture of devices or device parts, tubes, and bags within the medical industry.

The use of plastics in the medical industry initially came as a replacement option to metallic devices, because plastics offered better durability and lower cost of manufacturing. The most commonly used plastic in the medical industry used to be polyvinyl chloride (PVC), which quickly became a highly popular option. PVC has, however, been facing opposition due to growing environmental concerns regarding the method of its manufacture and disposal of devices and items made using PVC. Then there is the problem of PVC itself showing signs of being toxic. With all these points in view, we can see why styrenic polymers are being favored more in the medical industry today. Not only do styrenic polymer products display superior properties to PVC, but they are also a lot easier to recycle.

Key Players and their Reactions to the Growing PS Demand

Some of the key manufacturers operating in the global styrenic polymers market are Styron LLC, LG Chem Ltd., Chevron Phillips Chemical Company LLC, Chi Mei Corporation, Saudi Basic Industries Corporation, and Styrolution Group GmbH. In response to the growing demand from the global styrenic polymers market, Asahi Kasei, one of Japan’s biggest chemical companies, said that they would boost the yearly production capacity of its Kawasaki Works manufacturing plant in Kangawa, Japan. The increased capacity will go into manufacturing hydrogenated styrenic thermoplastic elastomer (SEBS). SEBS is a modifier which, when used with polypropylene, makes it more flexible while keeping it transparent. The product is a viable answer towards a growing market need for finding a more flexible alternative for PVC.

Browse Press Release on Styrenic Polymers Market: http://www.transparencymarketresearch.com/pressrelease/styrenic-polymers-market.htm

Today, perhaps the only reason PVC might be preferred over styrenic polymers is its cheaper cost. Technological advancement will, however, resolve this by lowering the cost of production once demand picks up steam. A high volume of R&D efforts are envisioned to occur in North America, the region that held the largest share in 2013 (39.9%). Even Asia Pacific is showing swift improvements in the global styrenic polymers market in terms of research, production, and usage. It can, therefore, safely be concluded that the global styrenic polymers market is here to stay for quite some time.

Efficacy of Spirotetramat in the Control of Pests will Drive the Market at 4.4% CAGR until 2020

Spirotetramat is a novel active ingredient from the chemical class of tetramic acids. It is an important innovation by Bayer CropScience in the field of foliar insecticides. When applied to foliage, spirotetramat penetrates the plant leaves or the leaf cuticle and gets transferred to other parts of the plant, such as to its growing shoots and down to the roots. In this way, spirotetramat market offers broad-spectrum control of many insects and pests such as aphids, thrips, mealy bugs, psyllids, and whiteflies on the plants.
 

Spirotetramat – An Innovative Insecticide for Integrated Pest Control

Spirotetramat’s innovative two-way system ensures the control of soil-living and hidden sucking pests and protects any new shoots set to grow on the plant. With the help of ingestion, the insecticide acts against insect larvae, too. These qualities are effective against difficult-to-control pests, hence leading to healthier crops.

Spirotetramat demonstrates both nematicidal and insecticidal activities. They are an important addition to the integrated pest management (IPM) programs in citrus fruits, grapes, vegetables, potatoes, and tree fruits.

 

Browse market research report of Spirotetramat Market:  

http://www.transparencymarketresearch.com/spirotetramat-market.html

The use of spirotetramat is highly recommended in integrated crop protection programs because it helps in overall crop protection and is also safe for insects such as lacewings and ladybugs that are beneficial for plant growth.

Spirotetramat is an innovative insecticide in the global market that offers good decomposition and residue benefits, making it well-suited to meet the high-quality standards set by the international food chain.
 

Spirotetramat is the best alternative to other traditional classes of active ingredients available on the market, as it helps extend the shelf life of these substances.

Wider adoption of insecticides such as spirotetramat, which helps in reducing the overall cost of pest management, is expected to boost the market growth of spirotetramat in the 2014-2020 forecast period. During this period, the market is expected to expand at a CAGR of 4.4% and reach US$233.1 million by 2020.

Bayer CropScience Expands Scope of Spirotetramat Patents

Bayer CropScience is the first global enterprise to receive regulatory approval for spirotetramat from the authorities in China.

Recently, the company took a large step forward to end the distribution of counterfeit crop protection products containing spirotetramat. Farmers utilizing these products, containing non-approved active substances, pose severe risks to the environment, land, consumer health and themselves.

Therefore, through the protection of patents, Bayer CropScience is now trying to be alert for any activities that break China’s intellectual property right laws, including trademarks, patents, and copyrights. It has taken the efforts to establish clear rules and regulations in China for the recognition of intellectual property (IP) rights. However, the patent acquired by Bayer CropScience is expected to expire by 2017 and new entrants in the market are expected to enter the market and grow thereafter.

Refrigerated Display Cases Market to Rise thanks to New Product Developments and Innovations

Refrigerated display cases/cabinets (RDCs) are the freezers or refrigerators that are especially designed for the purpose of storing and displaying food items of a temperature-sensitive nature or items that have to be kept chilled or frozen. These types of refrigerators are generally utilized in supermarkets and hypermarkets, grocery stores, hotels and restaurants, bakery shops, gas stations, catering businesses, and local or kiosk grocers. They can also be utilized in the biomedical sector for storing drugs and their specimens. The rise in the number of restaurants, cafes, supermarkets, and bakery outlets has brought about a change in the food consumption habits of individuals. This is responsible for fuelling the demand for both RDCs and chilled rooms.

Browse full market research report of Refrigerated Display Cases (RDCs) and Chilled Rooms Market: http://www.transparencymarketresearch.com/refrigerated-display-cases-chilled-rooms-market.html

There have been a large number of recent innovations and developments in this market and a variety of new products have been launched in the market. TMR, a market intelligence company based in the U.S, elaborates the cutting-edge models and products introduced in the market for RDCs and chilled rooms, along with stating their usage and benefits:

• VM: This is a type of display merchandise that utilizes static refrigeration especially for displaying dairy products, cold cuts of meat, and pre-packaged food products. This type of model is characterized by top-quality food preservation and is helpful in maintaining the organoleptic and nutritional properties of food items. In this model, great attention is given to the technical aspects of food preservation. This model is often introduced with optional accessories, along with the standard equipment.
• ELBA: This model provides static refrigeration for displaying certain kinds of food products such as prepackaged fresh food as well as seafood. Seafood needs a lot of attention and its particular organoleptic properties should ideally remain the same. ELBA display cases are helpful in maintaining these properties. Hence, ELBA display cases are a perfect combination of both quality and design and comprises aesthetic characteristics for the satisfaction of consumer demands.
• VMS:  This is a static refrigeration display chamber and is especially designed to display beverages. This model provides an elegant and unique design.  In this kind of display, the products are displayed in an orderly and clear manner and this is why this type of chamber is considered to be very unique. All the beverages are clearly displayed, which allows the consumers to without a hassle select their preferred product. This type of refrigeration chamber is especially utilized for the promotion and preservation of wine products. The key variants of VMS include 100 STD, 125 STD, and 150 STD.

Apart from these, there are a large variety of new and exclusive models being introduced in the market for RDCs and chilled rooms, which, along with maintaining the quality of food products, have elegant and classy designs and are substantially robust in nature. Some other newly launched products include Action, EXPO, ET, and SPOT, among others. These innovations are poised at stimulating the RDCs and chilled rooms market in the forthcoming future.

Get sample copy of report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4092

The key manufacturers dominant in this market include Dover Corporation, Frigoglass, Manitowoc Company, Inc., United Technologies Corporation, and Hoshizaki International.

3D Printing Inks and Better Printers to Contribute toward Growth of Printing Inks Market

The printing inks market has been growing at a steady rate across the globe and is estimated to tread a positive path in coming few years. According to a research report published by Transparency Market Research, the global printing inks market is expected to reach a value of US$20.17 billion by 2020 from the value of US$14.41 billion reported in 2013. This monumental growth will be steered by the flexible packaging segment, along with other packing materials that are used in several other industries.

Browse Full Market Research Report of Printing Inks Market: http://www.transparencymarketresearch.com/printing-inks-market.html

Analysts predict that the contribution of packaging to the printing inks market will continue to grow till 2020, as the industry will need inks for printing labels, tags, metal cans, and flexible materials. The printing inks market has picked up great speed as product designers are looking at various ways of making packaging interesting, catchy, and high-class.

Printers to Encourage Consumers to Spend More on Printing

Epson, a leading manufacturer of computer printers, is devising a special printer that will use lesser printing cartridge to encourage consumers to buy printers to begin with. The Epson EcoTank printer is expected to hit the market this September. It will be equipped with bigger, refillable ink tanks that will save the trouble of spending on a cartridge. The replacements inks will only cost the consumers US$13 to US$52, as compared to cartridges, which can cost up to US$70. Such innovations and minor tweaks to printing media are also expected to boost demand from the overall printing inks market.

3D Printing Inks Market to be Driven by Technological Progress

As designers, innovators, and artists are coming up with ink solutions for 3D printing techniques, the global printing ink market is also expected to expand in a new dimension. 3DT Labs is working its way around giving access to the world of color to various 3D printers across the globe. According to officials at 3DT Labs, 3D printing in color should not be a challenge. The solution to this Herculean task is being sought with Chameleon filament inking system. The company has been researching and developing this system for quite some time now. Endeavors to make 3D printing output colorful have has definitely opened a new avenue for the printing inks market to generate revenue from.

Get sample copy of report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=768

According to analysts at Transparency Market Research, North America is expected to lead the global printing inks market, which was also the leading region in 2013 with a market share of 30% in terms of volume. Research indicates that growth of the printing inks market in North America will be due to rise in the use of flexible packaging and commercial printing. The next region in line to witness significant growth will be Asia Pacific, with India and China experiencing significant growth till 2020.

Advanced Technology to Aid Medical Sector in Fine-tuning Patient Monitoring for Prolonged Pressure-Strained Skin Conditions

In the last two decades, the use of technology has brought tremendous efficiency and accuracy in medical treatments. Healthcare is advancing hand-in-hand with technology, with healthcare being a focus area of technology for optimal solutions for treatments and services.

In the Wearable Technologies Conference held in San Francisco in July 2015, in a breakthrough advancement, revolutionary wearable sensor technology was presented for medical personnel to monitor patient movement to help with ulcers and other hospital-acquired conditions and alert caregivers for changing position of susceptible patients.

Browse Market Research Report of Pressure Relief Devices Market: 
http://www.transparencymarketresearch.com/pressure-relief-devices.html

Pressure ulcers, commonly known as bedsores, are a grave problem in the U.S. According to statistics from the U.S. Department of Health and Human Services, more than 2.5 million Americans suffer from pressure ulcers each year, and almost 60,000 deaths occur each year due to complications from pressure ulcers.

High-profile cases, such as the death of actor Christopher Reeves from complications of pressure ulcers, highlight the fact that they can be lethal if left untreated.

What Causes the Development of Pressure Ulcer in Patients?

Bedsores or pressure sores are injuries to the skin and underlying tissue that happen due to prolonged pressure on the skin.

Constant pressure on the skin, which limits blood flow to the surface and nearby tissues, leads to the development of pressure ulcers. Other factors related to limited mobility can make the skin susceptible to damage and lead to pressure ulcers.

The three primary contributing factors are:

•  Sustained Pressure: In the instance of the skin and the underlying tissues being caught between the bone and a surface such as a bed or a wheelchair, the external pressure may be stronger than the pressure exerted by the blood in the capillaries and arterioles in the respective area. The lack of essential nutrients in the skin cells and tissues causes damage, and eventually death of these functional areas.
• Friction: Friction is produced as a result of resistance to motion in the instance of the skin being dragged across a surface, such as at the time of change of sleeping or sitting position. The intensity of friction is higher if the skin is moist. Repeated instances of friction make the skin fragile and more susceptible to injury.
• Shear: The instance of two surfaces moving in opposite direction leads to shear. For example, if the hospital bed is raised at the head, it enables the patient to slide down in the bed. During this action, as the tailbone changes position, the skin over the bone may not necessarily move and may essentially be pulled in the opposite direction. This may injure blood vessels and tissue, thus making the site vulnerable to damage.

Get sample copy this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1743

With mounting incidence of pressure ulcers coming on the surface due to myriad health reasons, Transparency Market Research (TMR) presents a detailed analysis of demand patterns for pressure relief devices that are the first-line treatment for such conditions, here’s a lowdown:

• Low-tech devices alleviate pressure experienced by patients on the skin and tissue due to their body weight.  The use of such devices help prevent ulcer and they are cost-effective and easy to use. The aforementioned factors led low-tech devices to dominate the global pressure relief devices market in 2013.
• Amongst the hi-tech devices, dynamic air therapy beds are highly efficient and effective for pressure ulcer treatment. For such reasons, the product segment is expected to register the highest growth in the next few years. 

India Sterilizers and Surgical, Dental Care, and Equipment Disinfectors Market: Hospital-Acquired Infections to Drive Valuation of Market to INR1,390.2 Crore by 2019

Hospital-acquired infections or HAIs are a major safety concern for both healthcare providers and patients. They are caused due to prolonged hospital stays and increase the mortality of hospitalized patients. The sterilizers and surgical, dental care and equipment disinfectors market in India is primarily driven by the growing prevalence of hospital-acquired infections.

According to the World Health Organization, the frequency of ICU-acquired and device-associated infections in low- and middle-income countries such as India is much higher than in high-income countries. Of every 100 hospitalized patients at any given time, 10 in developing countries will get affected with at least one healthcare-associated infection. It is estimated that with the growing number of patients affected with HAIs, the sterilizers and surgical, dental care and equipment disinfectors market in India will be worth INR1,390.2 Crore by 2020. 

Browse Market Research Report of Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market: 

http://www.transparencymarketresearch.com/sterilizers-surgical-dental-care-equipment-disinfectors-market.html

ICUs and Nursing Tables Pose High Risk of Hospital-Acquired Infections

Hospital-acquired infections are commonly caused by fungal, bacterial, and viral pathogens. In India and other developing economies, surgical site infections are the most common HAI, affecting up to one-third of operated patients. It can be attributed to inadequate environmental hygienic conditions and waste disposal, coupled with poor infrastructure.

A study by the Global Antibiotic Resistance Partnership (GARP) in association with the Center for Disease Dynamics, Economics and Policy revealed that in Indian ICUs, the risk of infections caused by vancomycin-resistant enterococcus (VRE), a deadly pathogen, is five times higher than in the rest of the world. Efforts to reduce the prevalence of HAIs have led to the extensive usage of formulations based on chlorhexidine gluconate to chemically disinfect ICUs and nursing tables in Indian hospitals.

Reasons behind Poor Infection Control Plans in Indian Hospitals 

The Ministry of Health and Family Welfare recommends that hospitals create an infection control plan to prevent the occurrence of HAIs. The problem often lies with the hospitals not following the infection control practices to curb the prevalence of the infections. Flouting infection control practices has resulted in some of the underlying problems in the Indian hospitals:

• Increasing number of patients per bed at government hospitals
• Less staff than required in hospitals
• Weak surveillance by ineffective infection control committees
• Lack of educational programs for healthcare workers, addressing basic infection control issues

Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market to Bring Positive Changes in Indian Healthcare Sector

A large number of hospital-acquired infections are easily preventable by stepping up hygiene practices such as the use of isolation rooms for infected patients, increased availability and uptake of diagnostic tests, limited catheter use, use of gloves and gowns, and increased hand-washing. 

Browse Press Release of Sterilizers and Surgical, Dental Care and Equipment Disinfectors Market: 

http://www.transparencymarketresearch.com/pressrelease/sterilizers-surgical-dental-care-equipment-disinfectors-market.htm

The sterilizers and surgical, dental care and equipment disinfectors market in India has a huge opportunity to grow with the development of protocols and programs to provide a hygienic environment in the hospitals. However, the medical sector in India has a long way to tread to effectively implement infection control practices. Changes at the organizational and administrative levels need to be introduced to provide better and infection-free healthcare facilities.